Skip to content

Clinical findings, hormonal tests, genetic tests and quality of life assessment in patients with abnormal male genitalia

Clinical profile, hormonal profile, genetic profile and quality of life assessment in patients with 46XY karyotype with Disorders of sex development - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/075441
Enrollment
60
Registered
2024-10-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Q562- Female pseudohermaphroditism, notelsewhere classified Health Condition 2: Q560- Hermaphroditism, not elsewhere classified Health Condition 3: Q541- Hypospadias, penile Health Condition 4: Q542- Hypospadias, penoscrotal Health Condition 5: Q543- Hypospadias, perineal Health Condition 6: Q564- Indeterminate sex, unspecified Health Condition 7: Q561- Male pseudohermaphroditism, not elsewhere classified Health Condition 8: Q563- Pseudohermaphroditism, unspecified Health Con

Interventions

Intervention1: NIL: no Intervention is given to the patients

Sponsors

Dept of Endocrinology, T.N. Medical College & BYL Nair Charitable Hospital, Mumbai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Overt genital ambiguity 2. Apparent female genitalia with an enlarged clitoris, posterior labial fusion, or an inguinal/labial mass 3. Apparent male genitalia with bilateral undescended testes, micropenis, isolated perineal hypospadias, or mild hypospadias with undescended testis 4. Discordance between genital appearance and a prenatal karyotype 5. External Masculinisation Score of less than 11 6. All patients with 46XY karyotype diagnosed to have disorders of sex development who provide consent to be part of the study

Exclusion criteria

Exclusion criteria: 1. Subjects diagnosed to have differences/ disorders of sex development who do not have a 46XY karyotype 2. Patients who do not consent to be part of study

Design outcomes

Primary

MeasureTime frame
To compare the clinical phenotype, hormonal profile and genetic profile among patients with various subtypes of 46XY DSDTimepoint: At the time of presentation in the outpatient dept of the hospital

Secondary

MeasureTime frame
To assess and compare patients within the various subtypes of 46XY DSD, the Gender identity/ Gender Role Behaviour/ Gender Dysphoria using questionnairesTimepoint: At the time of presentation in the outpatient dept of the hospital;To assess and compare patients within the various subtypes of 46XY DSD, the Patient’s Quality of life using questionnairesTimepoint: At the time of presentation in the outpatient dept of the hospital;To assess and compare patients within the various subtypes of 46XY DSD, the Patient’s sexual functionsTimepoint: At the time of presentation in the outpatient dept of the hospital;To assess and compare patients within the various subtypes of 46XY DSD, the Parent’s Quality of life using questionnairesTimepoint: At the time of presentation in the outpatient dept of the hospital

Countries

India

Contacts

Public ContactDr Abraham Alex Kodiatte

Topiwala National Medical College & Bai Yamunabai Laxman Nair Charitable Hospital, Mumbai

abrahamkodiatte@gmail.com9780280094

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026